Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert

This publication has 18 references indexed in Scilit:

• A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema
  Ophthalmology, 2008
• Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
  New England Journal of Medicine, 2006
• Ranibizumab for Neovascular Age-Related Macular Degeneration
  New England Journal of Medicine, 2006
• Fluocinolone Acetonide Implant (Retisert) for Noninfectious Posterior Uveitis
  Ophthalmology, 2006
• Comparison of Intravitreal versus Posterior Sub–Tenon’s Capsule Injection of Triamcinolone Acetonide for Diffuse Diabetic Macular Edema
  Ophthalmology, 2005
• Ocular Pharmacokinetics of Fluocinolone Acetonide After Retisert™ Intravitreal Implantation in Rabbits Over a 1-Year Period
  Journal of Ocular Pharmacology and Therapeutics, 2004
• Intravitreal triamcinolone acetonide for diabetic diffuse macular edema11The authors have no proprietary interest in this study. 22Dr Audren, co–first author, contributed equally to the work.
  Ophthalmology, 2004
• Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
  New England Journal of Medicine, 1997
• Intravitreal Sustained Release of VEGF Causes Retinal Neovascularization in Rabbits and Breakdown of the Blood– Retinal Barrier in Rabbits and Primates
  Experimental Eye Research, 1997
• The effect of TNF-α and IL-6 on the permeability of the rat blood-retinal barrier in vivo
  Acta Neuropathologica, 1996